Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02834975
Title Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC).
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Miami
Indications

ovary epithelial cancer

fallopian tube carcinoma

peritoneal carcinoma

Therapies

Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.